Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma

被引:76
作者
Mamo, JCL
Proctor, SD
Smith, D
机构
[1] Univ Western Australia, Dept Med, Perth, WA 6001, Australia
[2] Univ Western Australia, Dept Physiol, Perth, WA 6001, Australia
关键词
lesions; chylomicron remnants; clearance mechanism;
D O I
10.1016/S0021-9150(98)00220-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis is thought to begin with the trapping of cholesterol rich lipoproteins within the intima of arterial vessels. Thereafter a complex inflammatory cascade involving recruitment and transformation of leukocytes, accumulation of sterols in macrophages and cellular proliferation, can lead to a progressive occlusion in blood flow, or an unstable arterial lesion prone to prothrombotic events. Primary intervention strategies aimed at reducing atherogenesis are designed to achieve reductions in sterol rich lipoproteins, primarily low density lipoproteins, given the hypothesis that decreased exposure will attenuate the rate of arterial cholesterol accumulation. Epidemiological evidence has clearly identified a positive relationship between poor dietary (fat) habits and the onset and progression of atherosclerosis. However lipoproteins which mediate the transport of dietary lipid, that is chylomicrons, are not normally considered to be directly involved in atherogenesis, because of their larger size and inability to efficiently penetrate arterial tissue. In contrast, this article reviews recent evidence which suggests that once chylomicrons are hydrolysed to their remnant form, the triglyceride depleted chylomicron remnants penetrate arterial tissue and moreover, become preferentially trapped within the subendothelial space as concentrated focii. Ongoing studies demonstrate that significant chylomicron remnant accumulation can occur in a number of primary and secondary lipid disorders and in normolipidemic subjects with coronary artery disease. Chylomicron remnant dyslipidemia in conditions prone to premature atherosclerosis is consistent with the putative atherogenicity of these particles and can be explained by increased arterial exposure to cholesterol rich chylomicron remnants. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:S63 / S69
页数:7
相关论文
共 48 条
[1]   SERUM TRIGLYCERIDES IN CORONARY ARTERY DISEASE [J].
ALBRINK, MJ ;
MAN, EB .
ARCHIVES OF INTERNAL MEDICINE, 1959, 103 (01) :4-8
[2]   FAMILIAL XANTHOMATOUS HYPERCHOLESTEROLEMIA - ABNORMAL EXOGENOUS LIPID-METABOLISM EVIDENCED BY THE VITAMIN-A TEST [J].
ASSADOLLAHI, F ;
CAVALLERO, E ;
BUXTORF, JC ;
JACOTOT, B ;
BEAUMONT, JL .
ANNALS OF NUTRITION AND METABOLISM, 1994, 38 (05) :307-312
[3]  
BIESIEGEL U, 1994, ANN NY ACAD SCI, V10, P737
[4]   CHYLOMICRON-REMNANT CLEARANCE IN HOMOZYGOTE AND HETEROZYGOTE WATANABE-HERITABLE-HYPERLIPEMIC RABBITS IS DEFECTIVE - LACK OF EVIDENCE FOR AN INDEPENDENT CHYLOMICRON-REMNANT RECEPTOR [J].
BOWLER, A ;
REDGRAVE, TG ;
MAMO, JCL .
BIOCHEMICAL JOURNAL, 1991, 276 :381-386
[5]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[6]   Interaction of oxidized LDL with arterial proteoglycans [J].
Chait, A ;
Chang, MY ;
Olin, K ;
Wight, T .
ATHEROSCLEROSIS, 1997, 134 (1-2) :197-197
[7]  
CHOI SY, 1993, J BIOL CHEM, V268, P15804
[8]  
Cohn Jeffrey S., 1994, Current Opinion in Lipidology, V5, P185
[9]   POSTPRANDIAL LIPOPROTEIN METABOLISM IN NORMOLIPIDEMIC MEN WITH AND WITHOUT CORONARY-ARTERY DISEASE [J].
GROOT, PHE ;
VANSTIPHOUT, WAHJ ;
KRAUSS, XH ;
JANSEN, H ;
VANTOL, A ;
VANRAMSHORST, E ;
CHINON, S ;
HOFMAN, A ;
CRESSWELL, SR ;
HAVEKES, L .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (03) :653-662
[10]   CHYLOMICRON REMNANTS - HEPATIC RECEPTORS AND METABOLISM [J].
HAVEL, RJ .
CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (05) :312-316